Opterion ODR
Peritoneal Dialysis for End-Stage Renal Disease (ESRD)
Pre-clinicalActive
Key Facts
Indication
Peritoneal Dialysis for End-Stage Renal Disease (ESRD)
Phase
Pre-clinical
Status
Active
Company
About Opterion Health
Opterion Health is a clinical-stage biotech targeting the multi-billion-dollar dialysis market with a disruptive solution for peritoneal dialysis. Its lead product, Opterion ODR, is a novel osmotic driver composed of a proprietary polysaccharide (Decadextrin) and maltose, designed to provide effective fluid removal without the glucose-related metabolic complications of current standards. The company aims to make PD a more attractive, longer-lasting, and safer alternative to hemodialysis, potentially capturing significant market share in a large and growing renal disease sector.
View full company profile